Actively Recruiting
The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors
Led by TCI Co., Ltd. · Updated on 2025-01-09
60
Participants Needed
1
Research Sites
222 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the efficacy evaluation of buckwheat husk extract on cardiovascular disease risk factors
CONDITIONS
Official Title
The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 20 to 65 years, male or non-pregnant female willing to sign consent
- Systolic blood pressure between 121 and 139 mmHg and diastolic blood pressure between 81 and 89 mmHg
- Non-pregnant and willing to use contraception during the trial
- No history of organ transplantation, epilepsy or convulsions, liver or kidney disease, malignant tumor, endocrine disease, mental disease, alcohol or drug abuse, or other major organic diseases according to medical history
You will not qualify if you...
- Pregnant women
- History of organ transplantation, epilepsy or convulsions, liver or kidney disease, malignant tumors, endocrine diseases, mental illness, alcohol or drug abuse, or other major organic diseases according to medical history
- Individuals who have undergone major surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan, 114
Actively Recruiting
Research Team
S
Shyr-Chyr Chen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here